Pfizer Viagra revenue 2003-2019 - Statista

Pfizer's worldwide known erectile dysfunction product Viagra generated around 500 million U.S. dollars in revenue in 2019. Sales of this drug have decreased steadily over the past seven years ...

Erectile Dysfunction Drugs Market Size & Share Report, 2030

Erectile Dysfunction Drugs Market Trends. The global erectile dysfunction drugs market size was estimated at USD 2.92 billion in 2024 and is projected to grow at a CAGR of 9.13% from 2025 to 2030. The market is significantly influenced by several factors, including a rising geriatric population, increasing R&D efforts, and a growing prevalence of Erectile Dysfunction (ED).

Erectile Dysfunction Drugs Market Analysis | Industry Growth, Size ...

The Erectile Dysfunction Drugs Market size is expected to reach USD 4.52 billion in 2024 and grow at a CAGR of 7.06% to reach USD 6.36 billion by 2029. ... Sildenafil is sold under the trade name Viagra, which is highly well-known and earns its parent company, Pfizer, an estimated USD 1.8 billion annually. ... as per an article published by the ...

Chart: Viagra Sales Went Soft as Exclusivity Expired - Statista

25 years ago, on March 27, 1998, the U.S. Food and Drug Administration (FDA) approved Viagra for treatment of male erectile dysfunction. With its distinct blue diamond shape, Viagra quickly gained ...

Viagra outdoes competition with Q3 sales - Pharmaceutical Technology

Viagra's increase in 2020 Q3 sales is a significant boost in revenue for Pfizer from one of its most well-known drugs, yet it will not stop Viagra's sales erosion from the many generics available, with 2020 predicted to be the lowest recorded sales year to date for Viagra. Free Whitepaper ... As per recent sales enablement collective 2022 ...

Pfizer global Lipitor revenue 2003-2019 | Statista

In the year of patent loss - 2011 - Lipitor still generated roughly 10 billion dollars, before a heavy drop down to four billion dollars in 2012. ... Volume of drugs sold in pharmacies in ...